Liquid Biopsy – The necessary first step towards democratising precision oncology?African biotech holds the key to transforming not just the health of African people, but our economies as well
![](https://www.yemaachi.com/wp-content/uploads/2023/02/1675083715756.jpeg)
While IHC and imaging are useful for diagnosing and staging cancers, they are limited in their ability to inform clinical decision-making regarding the use of increasingly available targeted therapies that are revolutionising cancer care in developed countries. For this, more advanced molecular tests are required, and next generation sequencing-based liquid biopsy tests are at the cutting edge.
African biotech holds the key to transforming not just the health of African people, but our economies as well
![](https://www.yemaachi.com/wp-content/uploads/2022/11/Screenshot-2023-02-14-at-10.55.28-AM.png)
Why has over a decade of political rhetoric and unprecedented donor support for scientific capacity building not translated into more tangible scientific output?
A closer look reveals a glaring gap in the current structure of the scientific ecosystem in Africa – the almost complete absence of the private sector.